Document Preview Unavailable

CD34 as a potential prognostic indicator for camrelizumab response in advanced non-small-cell lung cancer: insights from digital spatial profiling

Huang, Xinyi; Tian Baoqing; Ren Ziyuan; Zhang, Jingxin; Yan, Weiwei; et al.  Therapeutic Advances in Medical Oncology Vol. 16,  (Jan 2024).

You might have access to this document